Article info

Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort

Authors

  1. Correspondence to Dr Sandip P Patel; spatel{at}ucsd.edu; Dr Young Kwang Chae; chaelabmeeting{at}gmail.com; Razelle Kurzrock; rkurzrock{at}mcw.edu
View Full Text

Citation

Patel SP, Othus M, Chae YK, et al
Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort

Publication history

  • Accepted July 9, 2024
  • First published July 27, 2024.
Online issue publication 
July 27, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.